StomaphyX: Difference between revisions
CSV import |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|Endoscopic suturing system for revisional bariatric procedures}} | |||
'''StomaphyX''' is an endoscopic suturing device designed to assist in revisional procedures for patients who have undergone Roux-en-Y gastric bypass surgery (RYGB). Over time, the small stomach pouch and its outlet (stoma) may enlarge in some patients, leading to weight regain. The StomaphyX device allows surgeons to reduce the size of the pouch and stoma without exposing the patient to the risks associated with invasive surgery. | |||
While initial studies have shown some degree of short-term weight loss, there is ongoing debate regarding the long-term effectiveness of this procedure. | |||
The StomaphyX device was developed and patented by EndoGastric Solutions, a company specializing in endoscopic therapies for gastrointestinal disorders. | |||
StomaphyX | |||
== | == Medical Uses == | ||
StomaphyX is primarily used by bariatric surgeons to reduce the volume of the stomach pouch in patients who have regained weight after Roux-en-Y gastric bypass surgery. Since weight regain is often associated with the gradual stretching of the stomach pouch, revisional procedures like StomaphyX are intended to restore a smaller pouch size. | |||
Potential benefits of using an endoscopic approach include: | |||
* Minimally invasive – No external incisions. | |||
* Lower surgical risks – Reduces the risk of complications compared to open or laparoscopic revisional surgery. | |||
* Shorter recovery time – Most patients can return to normal activities within a few days. | |||
However, the long-term success of the procedure remains uncertain. | |||
[[Category:Obesity]] | == Procedure and Technique == | ||
[[Category: | The StomaphyX procedure is performed using an endoscopic approach under general anesthesia or conscious sedation. The steps include: | ||
[[Category: | |||
1. Insertion of the Endoscope | |||
* A fiberoptic gastroscope is introduced through the mouth and esophagus into the stomach. | |||
* The StomaphyX device is inserted alongside the gastroscope. | |||
2. Creating Pleats in the Stomach Pouch | |||
* Using the device, the surgeon grabs folds of stomach tissue and creates pleats by securing them with polypropylene fasteners. | |||
* The goal is to reduce the volume of the stomach pouch, making it functionally smaller. | |||
3. Final Adjustments | |||
* Once an adequate reduction is achieved, the device is removed, and the procedure is completed. | |||
* The entire process typically lasts 30 to 60 minutes. | |||
== Effectiveness and Outcomes == | |||
Short-Term Weight Loss | |||
* Some patients experience modest weight loss within the first six months after the procedure. | |||
Long-Term Concerns | |||
* Weight loss may not be sustained over time for all patients. | |||
* Some studies have found that the procedure does not always achieve significant reductions in body mass index (BMI). | |||
Challenges and Limitations | |||
* Tissue durability – The pleats created by the device may loosen over time, leading to the gradual return of the stomach's original size. | |||
* Not FDA-approved for weight loss – StomaphyX has not received FDA approval for use as a primary weight-loss procedure. | |||
* Patient selection – It may be more effective in highly motivated patients who adhere to strict dietary and lifestyle changes. | |||
== Safety and Risks == | |||
As a minimally invasive procedure, StomaphyX generally has a low complication rate, but potential risks include: | |||
* Mild post-procedure pain or nausea. | |||
* Bleeding at the site of suturing. | |||
* Infection (rare). | |||
* Limited long-term effectiveness, requiring additional interventions. | |||
== Alternatives == | |||
Several other endoscopic and surgical options exist for revisional bariatric procedures, including: | |||
* Apollo OverStitch – An endoscopic suturing system with greater durability. | |||
* ROSE (Restorative Obesity Surgery, Endoscopic) – A similar endoscopic procedure for reducing stomach pouch size. | |||
* Traditional revisional bariatric surgery – Laparoscopic or open procedures that involve re-tightening or resizing the gastric pouch and stoma. | |||
== Future Developments == | |||
With the advancement of endoscopic techniques, newer devices with improved durability and effectiveness are being developed. Researchers are also exploring: | |||
* Biodegradable suturing materials for better long-term results. | |||
* Endoscopic stomach remodeling techniques that go beyond simple suturing. | |||
* Combination therapies that include dietary interventions and medication to enhance weight loss outcomes. | |||
== See Also == | |||
* [[Roux-en-Y gastric bypass]] | |||
* [[Bariatric surgery]] | |||
* [[Obesity treatment]] | |||
* [[Endoscopic suturing]] | |||
* [[Weight regain after bariatric surgery]] | |||
== External Links == | |||
* [https://www.endogastricsolutions.com/ EndoGastric Solutions] – Manufacturer of StomaphyX | |||
* [https://asmbs.org/ American Society for Metabolic and Bariatric Surgery] | |||
{{Obesity}} | |||
{{Bariatrics}} | |||
{{Gastroenterology}} {{stub}} | |||
{{DEFAULTSORT:StomaphyX}} | |||
[[Category:Bariatric surgery]] | |||
[[Category:Obesity treatment]] | |||
[[Category:Endoscopic procedures]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgical devices]] | |||
Latest revision as of 04:24, 20 March 2025
Endoscopic suturing system for revisional bariatric procedures
StomaphyX is an endoscopic suturing device designed to assist in revisional procedures for patients who have undergone Roux-en-Y gastric bypass surgery (RYGB). Over time, the small stomach pouch and its outlet (stoma) may enlarge in some patients, leading to weight regain. The StomaphyX device allows surgeons to reduce the size of the pouch and stoma without exposing the patient to the risks associated with invasive surgery.
While initial studies have shown some degree of short-term weight loss, there is ongoing debate regarding the long-term effectiveness of this procedure.
The StomaphyX device was developed and patented by EndoGastric Solutions, a company specializing in endoscopic therapies for gastrointestinal disorders.
Medical Uses[edit]
StomaphyX is primarily used by bariatric surgeons to reduce the volume of the stomach pouch in patients who have regained weight after Roux-en-Y gastric bypass surgery. Since weight regain is often associated with the gradual stretching of the stomach pouch, revisional procedures like StomaphyX are intended to restore a smaller pouch size.
Potential benefits of using an endoscopic approach include:
- Minimally invasive – No external incisions.
- Lower surgical risks – Reduces the risk of complications compared to open or laparoscopic revisional surgery.
- Shorter recovery time – Most patients can return to normal activities within a few days.
However, the long-term success of the procedure remains uncertain.
Procedure and Technique[edit]
The StomaphyX procedure is performed using an endoscopic approach under general anesthesia or conscious sedation. The steps include:
1. Insertion of the Endoscope
- A fiberoptic gastroscope is introduced through the mouth and esophagus into the stomach.
- The StomaphyX device is inserted alongside the gastroscope.
2. Creating Pleats in the Stomach Pouch
- Using the device, the surgeon grabs folds of stomach tissue and creates pleats by securing them with polypropylene fasteners.
- The goal is to reduce the volume of the stomach pouch, making it functionally smaller.
3. Final Adjustments
- Once an adequate reduction is achieved, the device is removed, and the procedure is completed.
- The entire process typically lasts 30 to 60 minutes.
Effectiveness and Outcomes[edit]
Short-Term Weight Loss
- Some patients experience modest weight loss within the first six months after the procedure.
Long-Term Concerns
- Weight loss may not be sustained over time for all patients.
- Some studies have found that the procedure does not always achieve significant reductions in body mass index (BMI).
Challenges and Limitations
- Tissue durability – The pleats created by the device may loosen over time, leading to the gradual return of the stomach's original size.
- Not FDA-approved for weight loss – StomaphyX has not received FDA approval for use as a primary weight-loss procedure.
- Patient selection – It may be more effective in highly motivated patients who adhere to strict dietary and lifestyle changes.
Safety and Risks[edit]
As a minimally invasive procedure, StomaphyX generally has a low complication rate, but potential risks include:
- Mild post-procedure pain or nausea.
- Bleeding at the site of suturing.
- Infection (rare).
- Limited long-term effectiveness, requiring additional interventions.
Alternatives[edit]
Several other endoscopic and surgical options exist for revisional bariatric procedures, including:
- Apollo OverStitch – An endoscopic suturing system with greater durability.
- ROSE (Restorative Obesity Surgery, Endoscopic) – A similar endoscopic procedure for reducing stomach pouch size.
- Traditional revisional bariatric surgery – Laparoscopic or open procedures that involve re-tightening or resizing the gastric pouch and stoma.
Future Developments[edit]
With the advancement of endoscopic techniques, newer devices with improved durability and effectiveness are being developed. Researchers are also exploring:
- Biodegradable suturing materials for better long-term results.
- Endoscopic stomach remodeling techniques that go beyond simple suturing.
- Combination therapies that include dietary interventions and medication to enhance weight loss outcomes.
See Also[edit]
- Roux-en-Y gastric bypass
- Bariatric surgery
- Obesity treatment
- Endoscopic suturing
- Weight regain after bariatric surgery
External Links[edit]
- EndoGastric Solutions – Manufacturer of StomaphyX
- American Society for Metabolic and Bariatric Surgery
| Obesity | ||
|---|---|---|
|
| Health science - Medicine - Gastroenterology - edit |
|---|
| Diseases of the esophagus - stomach |
| Halitosis | Nausea | Vomiting | GERD | Achalasia | Esophageal cancer | Esophageal varices | Peptic ulcer | Abdominal pain | Stomach cancer | Functional dyspepsia | Gastroparesis |
| Diseases of the liver - pancreas - gallbladder - biliary tree |
| Hepatitis | Cirrhosis | NASH | PBC | PSC | Budd-Chiari | Hepatocellular carcinoma | Acute pancreatitis | Chronic pancreatitis | Pancreatic cancer | Gallstones | Cholecystitis |
| Diseases of the small intestine |
| Peptic ulcer | Intussusception | Malabsorption (e.g. Coeliac, lactose intolerance, fructose malabsorption, Whipple's) | Lymphoma |
| Diseases of the colon |
| Diarrhea | Appendicitis | Diverticulitis | Diverticulosis | IBD (Crohn's, Ulcerative colitis) | IBS | Constipation | Colorectal cancer | Hirschsprung's | Pseudomembranous colitis |


